Kirsten Meid

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia”.

Long-term follow-up of ibrutinib monotherapy in treatment-naive patients with Waldenstrom macroglobulinemia

Leukemia(2021)10.1038/s41375-021-01417-9

N/A

1.8DataRank · unranked

83 citations

Kirsten Meid, Joshua Gustine, Carly Leventoff, Timothy P. White, Catherine Flynn +17 more

Phase 1 study of ibrutinib and the CXCR4 antagonist ulocuplumab in CXCR4-mutated Waldenström macroglobulinemia

Blood(2021)10.1182/blood.2021012953

N/A

1.4DataRank · unranked

53 citations

Kirsten Meid, Zachary R. Hunter, Catherine Flynn, Shayna Sarosiek, Carly Leventoff +17 more

Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas

Blood Advances(2020)10.1182/bloodadvances.2019000947

N/A

0DataRank · unranked

24 citations

Jiaji G. Chen, Manit Munshi, Zachary R. Hunter, Lian Xu, Amanda Kofides +12 more

The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance

Blood(2021)10.1182/blood.2021011405

N/A

0DataRank · unranked

28 citations

Jinhua Wang, Li Tan, Manit Munshi, Xia Liu, Amanda Kofides +17 more

Cell‐free DNA analysis for detection of MYD88L265P and CXCR4S338X mutations in Waldenström macroglobulinemia

American Journal of Hematology(2021)10.1002/ajh.26184

N/A

0DataRank · unranked

12 citations

Zachary R. Hunter, Lian Xu, Nicholas Tsakmaklis, Amanda Kofides, Manit Munshi +14 more

A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas

Blood Advances(2022)10.1182/bloodadvances.2021006147

N/A

0DataRank · unranked

15 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Maria Luisa Guerrera, Zachary R. Hunter +18 more

Identification of robust predictors for ibrutinib response by multiomics in MYD88-mutated Waldenström macroglobulinemia

Blood Advances(2024)10.1182/bloodadvances.2023012111

N/A

0DataRank · unranked

4 citations

Jorge J. Castillo, Shayna Sarosiek, Andrew R. Branagan, Catherine Flynn, Kirsten Meid +12 more

ERK1/2 pro‐survival signalling is suppressed by pirtobrutinib in ibrutinib‐resistant MYD88‐mutated lymphoma cells

British Journal of Haematology(2024)10.1111/bjh.19756

N/A

0DataRank · unranked

3 citations

Xia Liu, Amanda Kofides, Nickolas Tsakmaklis, Zachary R. Hunter, Maria Luisa Guerrera +15 more

The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients

Blood(2020)10.1182/blood.2020006288

N/A

0DataRank · unranked

340 citations

Jorge J. Castillo, Alan P Skarbnik, Jacob D. Soumerai, Irene M. Ghobrial, Maria Luisa Guerrera +3 more

Repurposing pacritinib to target MYD88 ‐mutated Waldenström macroglobulinaemia

British Journal of Haematology(2025)10.1111/bjh.70254

N/A

0DataRank · unranked

0 citations

Amanda Kofides, Xia Liu, John M. Hatcher, Hao Sun, Nicholas Tsakmaklis +11 more

SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas

Blood Cancer Journal(2020)10.1038/s41408-020-0277-6

N/A

0DataRank · unranked

47 citations

Xia Liu, Jiaji G. Chen, Lian Xu, Nickolas Tsakmaklis, Maria Demos +19 more